Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-03-07Clinical Trial Update: EEG Biomarkers for Predicting Response to Antidepressant Therapy
The trial evaluated EEG biomarkers to predict response to antidepressant therapy in major depressive disorder. The study status is completed…
-
FDA approval · 2012-03-06FDA Approved: LITHIUM CARBONATE — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved a supplemental application for lithium carbonate submitted by Camber Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2012-03-06Clinical Trial Update: A Study in the Treatment of Children and Adolescents With Major Depressive Disorder [Phase 3]
Phase 3 trial update for treatment of children and adolescents with major depressive disorder; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2012-03-05Clinical Trial Update: Study of Escitalopram in Adult Patients With Major Depressive Disorder [Phase 3]
A Phase 3 trial evaluating escitalopram for major depressive disorder in adults has completed. The sponsor is Forest Laboratories.
-
CLINICAL_TRIALS trial_result · 2012-03-05Clinical Trial Update: Study of the Effectiveness of Vestibular Stimulation as a Coadjuvant Treatment in Major Depression [NA]
This completed clinical trial evaluated the effectiveness of vestibular stimulation as an adjunctive therapy for major depressive disorder.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-03-05Clinical Trial Update: Comparison of Escitalopram Combination in Adult Patients With Major Depressive Disorder [Phase 3]
A Phase 3 clinical trial evaluating escitalopram combination therapy for adults with major depressive disorder has completed.
-
CLINICAL_TRIALS trial_result · 2012-02-29Clinical Trial Update: Understanding the Impact of Meditative Homework on Metacognitive Processes in the Context of Mindfulness Based Cognitive Therapy (MBCT)
This completed clinical trial assesses how meditative homework affects metacognitive processes in the context of Mindfulness-Based Cognitive…
-
FDA approval · 2012-02-28FDA Approved: FLUOXETINE — Supplemental Application (QUALLENT PHARMACEUTICALS HEALTH LLC)
FDA approves a supplemental application for a generic fluoxetine hydrochloride product from Quallent Pharmaceuticals Health LLC.
-
FDA approval · 2012-02-28FDA Approved: FLUOXETINE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approves the supplemental application for fluoxetine from Alembic Pharmaceuticals Limited, enabling the generic fluoxetine product to be…
-
CLINICAL_TRIALS trial_result · 2012-02-23Clinical Trial Update: A Safety, Efficacy and Tolerability Study of SEP-225289 [Phase 2]
This clinical trial update describes the completed Phase 2 study of SEP-225289 in major depressive disorder, assessing safety, efficacy, and…
-
CLINICAL_TRIALS trial_result · 2012-02-22Clinical Trial Update: Duke Conte Center for the Neuroscience of Depression in Late Life
This clinical trial update notes that the Duke Conte Center study on late-life major depressive disorder has completed.
-
CLINICAL_TRIALS trial_result · 2012-02-22Clinical Trial Update: A Study of Eszopiclone in Subjects With Insomnia Related to Major Depressive Disorder [Phase 3]
Phase 3 study of eszopiclone in insomnia related to major depressive disorder has completed.
-
CLINICAL_TRIALS trial_result · 2012-02-22Clinical Trial Update: A Study of Eszopiclone Co-administered With Venlafaxine in Subjects With Major Depressive Disorder and Insomnia [Phase 3]
Phase 3 trial evaluating co-administration of eszopiclone with venlafaxine for major depressive disorder with insomnia has completed.
-
FDA approval · 2012-02-21FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved Amneal Pharmaceuticals of New York LLC's supplemental application for bupropion hydrochloride (generic), confirming approval fo…
-
CLINICAL_TRIALS trial_result · 2012-02-17Clinical Trial Update: Study Comparing Discontinuation Symptoms Of DVS SR In Subjects With Major Depressive Disorder (MDD) [Phase 4]
A Phase 4 Pfizer trial in adults with major depressive disorder compares discontinuation symptoms after stopping the DVS SR formulation.
-
CLINICAL_TRIALS trial_result · 2012-02-15Clinical Trial Update: An International Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression [Phase 3]
An international Phase 3 study evaluating the safety and tolerability of Corlux for psychotic symptoms in psychotic major depression has com…
-
CLINICAL_TRIALS trial_result · 2012-02-15Clinical Trial Update: A United States Study of Corlux for Psychotic Symptoms in Psychotic Major Depression [Phase 3]
Phase 3 US study of Corlux for psychotic symptoms in psychotic major depression has completed.
-
CLINICAL_TRIALS trial_result · 2012-02-15Clinical Trial Update: A United States Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression [Phase 3]
Phase 3 US study evaluating the safety and tolerability of Corlux for psychotic symptoms in psychotic major depression has completed.
-
CLINICAL_TRIALS trial_result · 2012-02-15Clinical Trial Update: An International Extension Study of Corlux for Recurrent Psychotic Symptoms in Psychotic Major Depression [Phase 3]
An international extension study of Corlux (mifepristone) in recurrent psychotic symptoms of psychotic major depression (Phase 3), with comp…
-
CLINICAL_TRIALS trial_result · 2012-02-15Clinical Trial Update: Repetitive Transcranial Magnetic Stimulation Compared or Associated With Venlafaxine for Depressive Disorder [Phase 3]
Phase 3 clinical trial update evaluating repetitive transcranial magnetic stimulation (rTMS) with or alongside venlafaxine for major depress…
-
CLINICAL_TRIALS trial_result · 2012-02-13Clinical Trial Update: A Study in Depression and Associated Painful Physical Symptoms [Phase 4]
Phase 4 clinical trial evaluating Major Depressive Disorder with associated painful physical symptoms; results have been posted.
-
CLINICAL_TRIALS trial_result · 2012-02-10Clinical Trial Update: Transcranial Direct Current Stimulation (tDCS) in the Treatment of Major Depressive Disorder (MDD) [NA]
This ClinicalTrials.gov update reports on the completion of a trial evaluating transcranial direct current stimulation (tDCS) as a treatment…
-
CLINICAL_TRIALS research · 2012-02-09Clinical Trial Update: Childhood Sexual Abuse, Vaginismus and Labor Dystocia
This ClinicalTrials.gov update describes a study exploring relationships among childhood sexual abuse, vaginismus, and labor dystocia. The u…
-
CLINICAL_TRIALS research · 2012-02-09Clinical Trial Update: Longitudinal Study of People Presenting for First Treatment of a Mood Disorder
McMaster University is conducting a longitudinal study of people presenting for their first treatment of mood disorders, including major dep…
-
CLINICAL_TRIALS trial_result · 2012-02-08Clinical Trial Update: Quetiapine Extended Release (XR) for the Treatment of Menopausal Depression [Phase 4]
Phase 4 trial update shows completed study evaluating quetiapine extended-release for menopausal depression, including major depressive diso…